TSC2 and acute myeloid leukemia: PD-L2 protein expression was markedly enhanced in TSC2(−) AML cells when compared to the wild-type control (Fig. 5c) and its expression was ablated when NF-κB was inhibited with 5 μM BMS345541 (Fig. 5d).